Michael Sawyer

Professor

University of Alberta

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Nutrition Nutrition professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Sawyer is a Professor at the University of Alberta, Canada. His research focuses on the effects of dietary choices and body composition in cancer patients, as evidenced by his recent articles on topics such as protein intake in colorectal cancer and the optimization of pancreatic enzyme replacement therapy. He also explores the prognostic value of skeletal muscle in various malignancies, demonstrating a commitment to advancing knowledge in cancer treatment and nutrition.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Wendy Wismer

University of Alberta

CANADA

View details

Barbara van der Meij

Bond University

AUSTRALIA

View details

Kathryn N. Porter Starr

UNITED STATES

View details

Nicolaas Deutz

Professor

Texas A&M University

UNITED STATES

View details

Timothy Yap

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Sawyer

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects

Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanced pancreatic cancer and exocrine pancreatic insufficiency

Feasibility of two levels of protein intake in patients with colorectal cancer: findings from the Protein Recommendation to Increase Muscle (PRIMe) randomized controlled pilot trial

Drivers of Dietary Choice After a Diagnosis of Colorectal Cancer: A Qualitative Study

Skeletal muscle is prognostic in resected stage III malignant melanoma

An exploratory study of body composition as a predictor of dose-limiting toxicity in metastatic pancreatic cancer treated with gemcitabine plus nab-paclitaxel

Plasma levels of platinum-induced fatty acid [16:4n-3] do not affect response to platinum-based chemotherapy: A pilot study in non-small cell lung cancer patients

Protein Recommendation to Increase Muscle (PRIMe): Study protocol for a randomized controlled pilot trial investigating the feasibility of a high protein diet to halt loss of muscle mass in patients with colorectal cancer.

Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma

Profiling Determinants of Resting Energy Expenditure in Colorectal Cancer

Collaborators (5)

Wendy Wismer

Barbara van der Meij

Kathryn N. Porter Starr

Nicolaas Deutz

Timothy Yap

Make your next move.